BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Aravive Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

  Aravive, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided corporate updates.

  August 11, 2022

   · 

  12 min read
• Business

  Trevena Reports Second Quarter 2022 Results and Provides Business Update

  Trevena, Inc. today reported its financial results for the second quarter ended June 30, 2022 and provided an overview of its recent operational highlights.

  August 11, 2022

   · 

  20 min read
• Business

  Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update

  Altimmune, Inc. today announced financial results for the three and six months ended June 30, 2022, and provided a business update.

  August 11, 2022

   · 

  12 min read
• Business

  Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update

  Cabaletta Bio, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided a business update.

  August 11, 2022

   · 

  11 min read
• Business

  Optinose Reports Second Quarter 2022 Financial Results and Operational Updates

  Optinose today reported financial results for the quarter ended June 30, 2022, and provided operational updates.

  August 11, 2022

   · 

  16 min read
• Business

  Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update

  Fulcrum Therapeutics, Inc.® today reported financial results for the second quarter of 2022 and announced a strategic plan to realign internal resources to support the two clinical programs that are expected to be the key drivers of near-term value and extend cash runway.

  August 11, 2022

   · 

  9 min read
• Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

  Lucira Health, Inc. today announced that Health Canada has granted Authorization under Interim Order for the emergency use and commercialization of the first and only at-home test for COVID & Flu.

  August 11, 2022

   · 

  7 min read
• Business

  Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

  Taysha Gene Therapies, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

  August 11, 2022

   · 

  10 min read
• Business

  Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights

  Shattuck Labs, Inc. today reported financial results for the quarter ended June 30, 2022 and provided recent business highlights.

  August 11, 2022

   · 

  14 min read
• Biotech Bay

  ASLAN Pharmaceuticals Announces Three Abstracts Highlighting New Eblasakimab Data Have Been Accepted as E-Posters at the 31st European Academy of Dermatology and Venereology (EADV) Congress

  ASLAN Pharmaceuticals today announced that three abstracts, showcasing new findings related to eblasakimab, will be displayed as e-posters throughout the 31st European Academy of Dermatology and Venereology (EADV) Congress, to be held in-person and virtually from September 7 to 10, 2022.

  August 11, 2022

   · 

  2 min read